Press releases
2018
13 December, 2018
PledPharma presents results from study on drug candidate Aladote® for paracetamol poisoning at a global toxicology conference
23 October, 2018
Interim Report January-September 2018
28 September, 2018
Study drug for the PledOx® global phase III program delivered
22 August, 2018
Half-Year Report January-June 2018
25 June, 2018
PledPharma establishes a Scientific Advisory Board for the continued clinical development of Aladote®
25 June, 2018
Aladote® is concluded as safe in first clinical study – PledPharma aims to apply for Orphan Drug Status in the US
13 June, 2018
Japanese Medical Agency (PMDA) supports the expansion of the Phase III program for PledOx® to include Japanese patients
24 April, 2018
Interim Report January-March 2018
28 March, 2018
PledPharma receives European approval of the composition of matter patent for PledOx® and Aladote®
22 February, 2018
Year-end Report January-December 2017